Jamjoom Pharmaceuticals Factory Company Stock

Equities

4015

SA15QGU1UNH6

Pharmaceuticals

Market Closed - Saudi Arabian S.E. 08:20:04 2024-05-30 am EDT 5-day change 1st Jan Change
132.6 SAR +1.22% Intraday chart for Jamjoom Pharmaceuticals Factory Company +0.76% +15.30%
Sales 2024 * 1.32B 352M Sales 2025 * 1.47B 392M Capitalization 9.28B 2.48B
Net income 2024 * 366M 97.66M Net income 2025 * 402M 107M EV / Sales 2024 * 6.8 x
Net cash position 2024 * 318M 84.85M Net cash position 2025 * 485M 129M EV / Sales 2025 * 5.98 x
P/E ratio 2024 *
25.4 x
P/E ratio 2025 *
23.1 x
Employees -
Yield 2024 *
2.37%
Yield 2025 *
2.64%
Free-Float 30%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.22%
1 week+0.76%
1 month+2.16%
3 months-8.17%
6 months+16.32%
Current year+15.30%
More quotes
1 week
128.20
Extreme 128.2
134.00
1 month
128.20
Extreme 128.2
143.80
Current year
112.80
Extreme 112.8
158.20
1 year
66.00
Extreme 66
158.20
3 years
66.00
Extreme 66
158.20
5 years
66.00
Extreme 66
158.20
10 years
66.00
Extreme 66
158.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 21-05-14
Director of Finance/CFO 60 13-01-12
Chief Operating Officer 29 21-08-31
Members of the board TitleAgeSince
Director/Board Member - 22-06-18
Chairman 64 22-06-18
Founder 39 22-06-18
More insiders
Date Price Change Volume
24-05-30 132.6 +1.22% 177,309
24-05-29 131 -1.21% 106,869
24-05-28 132.6 -.--% 113,106
24-05-27 132.6 +1.22% 92,804
24-05-26 131 -0.46% 36,298

Delayed Quote Saudi Arabian S.E., May 30, 2024 at 08:20 am EDT

More quotes
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based Company, which produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates two segments, which include pharmaceutical products, that represents medicines or drugs, which all are essential for the prevention and treatment of diseases, and protection of public health; and Consumer health products segment that represents the products sold directly to consumers. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
132.6 SAR
Average target price
146.6 SAR
Spread / Average Target
+10.57%
Consensus

Quarterly revenue - Rate of surprise